Diabetes experts met and determined that some self-monitoring blood glucose (SMBG) systems, despite meeting accuracy standards at the time of U.S. Food and Drug Administration (FDA) clearance, fail to consistently meet accuracy standards once on the market, potentially putting patient health at risk. In a public meeting convened by the Diabetes Technology Society on May 21, 2013, in Arlington, Virginia, leading academic clinicians, clinical chemists, medical device experts, patient advocates and FDA representatives reviewed a growing body of peer-reviewed research demonstrating that the performance of some blood glucose monitors on the market may not be meeting accuracy standards.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61870-diabetes-technology-society-inaccurate-blood-glucose-monitors-risky
People who don’t have diabetes think that they are ok. But the way so many people eat, they put themselves at risk for this disease. Eating a diet high in processed foods, high sugar, and simple carbohydrates increase your chances of Type II Diabetes and especially if you are overweight. Other risk factors for Type II Diabetes are elevated triglyceride, low HDL, and high blood pressure.
Two Merck research scientists, Nancy A. Thornberry and Ann E. Weber, Ph.D., will receive the Discoverers Award, the highest honor from the Pharmaceutical Research and Manufacturers of America (PhRMA), during a ceremony tonight at the Liberty Science Center in Jersey City, N.J.
They will be recognized for their leadership in the discovery of JANUVIA®, a once-daily pill that helps patients with type 2 diabetes control glucose in conjunction with diet and exercise. Though women have been part of teams honored with the Discoverers Award in the past, this is the first time in the award’s 24-year history that women alone have won.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/phrma/49723/
Beginning in mid-March, the AARP/Walgreens Wellness Tour will once again travel the country, embarking on a ten-month tour to provide an expected $14 million worth of free health tests. The national mobile tour will conduct free health-testing events in communities throughout the United States and Puerto Rico. The free tests—which include total cholesterol levels, blood pressure, bone density, glucose levels, waist circumference and body mass index—are valued at $100 per person and may help provide adults with a critical foundation for early disease detection and prevention.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/walgreens/48029/
